Skinvisible, Inc. (OTCQB: SKVI) is working toward developing a transdermal treatment for post-traumatic stress disorder through its patented Invisicare® technology that could address the devastating number of veteran suicides that occur throughout the country. The company’s proposed merger with Quoin Pharmaceuticals would direct Skinvisible’s drug delivery capacity to boost the bioavailability of Quoin’s promising pharmaceuticals. An article discussing this reads: “Skinvisible, through its wholly owned subsidiary Skinvisible Pharmaceuticals, Inc., has already developed, licensed and sold multiple dermatology and health care products, as well as various medical treatments, using its patented Invisicare® technology. … Quoin’s two lead products are targeting crises that result in the death of almost 120 people in the U.S. every day. Data released September 15, 2017, by the U.S. Department of Veteran Affairs (“VA”) show that the risk for suicide was 22 percent higher among veterans when compared to civilians.”
To view the full article, visit http://cnw.fm/b9zFq
About Skinvisible Pharmaceuticals, Inc.
Skinvisible Pharmaceuticals is a research and development company that licenses its proprietary formulations made with Invisicare®, its patented polymer delivery system that offers life-cycle management and unique enhancements for topically delivered products. Invisicare holds active ingredients on the skin for extended periods of time, allowing for the controlled release of actives. For more information, visit the company’s website at www.Skinvisible.com
More from CannabisNewsBreaks
- CannabisNewsBreaks – SinglePoint, Inc. (SING) President Featured in Article Discussing Treasury Secretary’s Recent Cannabis Banking Comments
- CannabisNewsBreaks – Earth Science Tech, Inc. (ETST) Unveils Launch Date for Revamped Industrial Hemp CBD Products
- CannabisNewsBreaks – Global Payout, Inc. (GOHE) Subsidiary Pursuing Launch of Cannabis-Focused Cryptocurrency
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
For more information please visit https://www.CannabisNewsWire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net
